https://www.lymemind.org (Register Here & to View More Details)
5th Annual LymeMIND Virtual Conference 2020
We’re bringing together researchers, patients, sponsors, and other interested parties to share knowledge and experience related to Lyme disease research. To ensure the safety of all the attendees, we’ve decided to conduct this year’s conference in a virtual half-day program. We’ll be offering pre-recorded presentations and panel discussions. There will be a live Q&A after each segment.
- Saturday, October 10
- 9am-1pm
- Virtual Event
Advancing Lyme disease research through an integrated network of researchers, patients, physicians, and sponsors.
Registration is open
AGENDA
Chairperson – Welcome & Opening Remarks
-
Patricia (Savi) Glowe
KEYNOTE – “Chronic: The Hidden Cause of Autoimmune Pandemic and How to Get Healthy Again.”
-
Steven Phillips, MD
-
Dana Parish
Mothers and Children Panel Discussion – Phyllis Bedford – Moderator
-
Phyllis Bedford
-
Holly Ahern, MT(ASCP)
-
Sue Faber, RN, BScN
-
Charlotte, Mao, MD
COVID-19- in the context of Lyme disease
-
Jason Bobe, MSc
-
Richard Horowitz, MD
-
David Putrino, PT, PhD
Insights from Data Mining of Lyme Disease Patients by LymeMIND
-
Avi Ma’ayan, PhD
Novel Treatments: Making sense of all the treatment options – Panel – John Aucott – Moderator
-
John Aucott, MD
-
Tania Tyles Dempsey, MD, ABIHM
-
Andrew Petterson, DO
-
Richard Horowitz, MD
Bartonella and Co-infections
-
Marna Ericson, PhD
-
Robert Mozayeni, MD
-
Monica Embers, PhD
-
Edward Breitschwerdt, DVM
Lyme Disease – 5 years of progress
-
Jason Bobe, MSc
Call to Action: Center for Lyme Action
-
Bonnie L. Crater
Lyme Biobank’s tissue repository
-
Liz Horn, PhD, MBIP
Looking towards the future
-
Bennett Nemser MPH, MBA
-
John Aucott, MD
-
Brian A. Fallon, MD, MPH
LymeX Innovation Accelerator
-
ADM Brett P. Giroir, MD
-
Kristen Honey, PhD, PMP
-
Eric D. Hargan, JD, BA
Savi Glowe – Closing Remarks
-
Patricia (Savi) Glowe
LymeMIND utilizes innovation, transparency and collaboration to accelerate the field of Lyme disease research.
Through our integrated knowledge base, we aim to help Lyme disease researchers identify novel biomarkers and therapeutic target candidates. LymeMIND brings together leaders in Lyme disease research through collaborations, educational events, and an annual conference.
LymeMIND is made possible by generous support from the Cohen Lyme & Tickborne Disease Initiative. Launched in 2015, the Initiative seeks to gather the brightest minds within the research and medical communities to better understand and ultimately stop the rapid spread of tickborne illnesses. It has committed over $60 million to more than 25 research projects across the nation.
